WallStSmart

American Healthcare REIT, Inc. (AHR)vsChiron Real Estate Inc. (XRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American Healthcare REIT, Inc. generates 1425% more annual revenue ($2.26B vs $148.06M). AHR leads profitability with a 3.1% profit margin vs -3.9%. AHR earns a higher WallStSmart Score of 46/100 (D+).

AHR

Hold

46

out of 100

Grade: D+

Growth: 8.0Profit: 4.5Value: 3.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.62

XRN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 4.5Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHRSignificantly Overvalued (-162.1%)

Margin of Safety

-162.1%

Fair Value

$19.66

Current Price

$48.11

$28.45 premium

UndervaluedFair: $19.66Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHR2 strengths · Avg: 9.0/10
EPS GrowthGrowth
306.2%10/10

Earnings expanding 306.2% YoY

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

XRN2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
25.1%8/10

Strong operational efficiency at 25.1%

Areas to Watch

AHR4 concerns · Avg: 2.5/10
Return on EquityProfitability
2.5%3/10

ROE of 2.5% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

P/E RatioValuation
125.5x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-14.09M2/10

Negative free cash flow — burning cash

XRN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$934.84M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Return on EquityProfitability
-127.0%2/10

ROE of -127.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AHR

The strongest argument for AHR centers on EPS Growth, Price/Book. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on Price/Book, Operating Margin.

Bear Case : AHR

The primary concerns for AHR are Return on Equity, Profit Margin, P/E Ratio. A P/E of 125.5x leaves little room for execution misses. Thin 3.1% margins leave little buffer for downturns.

Bear Case : XRN

The primary concerns for XRN are EPS Growth, Market Cap, PEG Ratio.

Key Dynamics to Monitor

AHR profiles as a value stock while XRN is a turnaround play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.21 — expect wider price swings.

AHR is growing revenue faster at 11.9% — sustainability is the question.

XRN generates stronger free cash flow (18M), providing more financial flexibility.

Bottom Line

AHR scores higher overall (46/100 vs 41/100) and 11.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Healthcare REIT, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

American Healthcare REIT, Inc. is a prominent real estate investment trust focused on the acquisition and management of a diversified portfolio of high-quality healthcare facilities across the United States. Specializing in senior housing, skilled nursing, and medical office properties, the company collaborates with leading operators to guarantee stable cash flows and sustainable growth. By prioritizing the enhancement of resident and patient quality of life, American Healthcare REIT is strategically positioned to benefit from the expanding healthcare real estate sector, presenting a compelling investment opportunity for institutional investors in an essential services market.

Visit Website →

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?